bronchiectasis

Alderley Park, Cheshire, U.K., May 21, 2026 Infex Therapeutics announced positive Phase IIa clinical trial results for RESP-X (INFEX702)...

BRIDGEWATER, NEW JERSEY, May 04, 2026 Insmed Incorporated has announced the presentation of multiple clinical and real-world data sets...